Sandoz's $400m deal with US states in generic drug case gets preliminary approval
( October 19, 2026, 15:24 GMT | Official Statement) -- MLex Summary: Sandoz’s $400 million settlement with 48 attorneys general has been granted preliminary approval to resolve claims that it conspired to artificially inflate generic drug prices and reduce competition. See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.